AHAyşe Hoşoğlu

Ayşe Hoşoğlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayşe Hoşoğlu has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Admission Endothelial Activation and Stress Index in Acute Myocardial Infarction: Incremental Value Beyond the GRACE Score and a Test of the Index Weights

    by Kader Eliz Şahin, Ahmet Berk Duman, Şadiye Nur Dalgıç, Denizhan Karaçimen, Yalçın Dalgıç, Metin Çağdaş, Sedat Avcı, Ayşe Hoşoğlu

    Background/Objectives: The Endothelial Activation and Stress Index (EASIX), calculated from lactate dehydrogenase, creatinine and platelet count, has been linked to mortality in cardiovascular cohorts. We examined whether admission EASIX adds prognostic information to the Global Registry of Acute Coronary Events (GRACE) score for in-hospital mortality in acute myocardial infarction (AMI), and whether its fixed weights are supported. Methods: We retrospectively studied consecutive adults with AMI undergoing coronary angiography; patients with an estimated glomerular filtration rate below 30 mL/min/1.73 m2 were excluded. EASIX was modelled on the log2 scale. Incremental value was assessed against a GRACE model refitted in this cohort and against the published GRACE risk after recalibration, by discrimination, calibration, decision curves and bootstrap validation. Results: In-hospital death occurred in 225 of 4777 patients (4.7%). Each doubling of EASIX was associated with mortality after adjustment for the GRACE score (odds ratio 2.386, 95% confidence interval 2.053–2.774) and after clinical adjustment (2.363, 1.974–2.828). Adding EASIX raised the area under the curve from 0.855 to 0.890 (optimism-corrected increment 0.034, 95% confidence interval 0.025–0.052) and improved the Brier score and net benefit. Added to the recalibrated published GRACE risk, EASIX raised the area under the curve from 0.856 to 0.881 (corrected increment 0.024, 0.012–0.040). Findings were consistent in both infarct types. Freely estimated weights differed from the fixed weights but added little discrimination. Conclusions: Admission EASIX was independently associated with in-hospital mortality in AMI and added discrimination and net benefit to both a refitted and the published GRACE risk. External validation is required before clinical use.

  • The Celiac Culprit: Isolated Celiac Artery Stenosis Masquerading as Acute Coronary Syndrome With Marked Troponin Elevation: A Case Report

    by Yusuf Hosoglu, Ayse Hosoglu, Seyhmus Erkan Demircan, Faruk Ertas

    Marked troponin elevation, indicative of myocardial injury, typically prompts evaluation for acute coronary syndrome (ACS). However, extra‐cardiac pathologies can produce identical biomarker patterns, potentially diverting diagnostic reasoning and delaying definitive treatment. Isolated celiac artery stenosis is an uncommon cause of mesenteric ischemia that can mimic ACS. A 78‐year‐old woman presented with recurrent epigastric pain and significant troponin elevation (peak 2.492 ng/mL) despite non‐obstructive coronary arteries. Selective abdominal angiography revealed isolated high‐grade celiac artery stenosis with patent superior mesenteric artery (SMA) and inferior mesenteric artery (IMA). The lesion was treated with a self‐expanding stent, resulting in complete symptom resolution. Four years later, the patient re‐presented with identical symptoms and troponin elevation. Imaging demonstrated focal in‐stent restenosis, which was successfully treated with a balloon‐expandable stent, achieving durable symptom relief. This case illustrates that isolated celiac artery stenosis can closely mimic ACS, producing marked troponin release in the absence of coronary obstruction. Recognition of this masquerading visceral ischemia requires careful attention to symptom patterns and a low threshold for visceral angiography. Durable outcomes can be achieved with endovascular therapy, even in cases of restenosis.

  • Long-Term Prognosis of Acute Myocardial Infarction Caused by Isolated Diffuse Coronary Artery Ectasia

    by Adnan Abaci, Murat Gökhan Yerlikaya, Tuğba Kapanşahin, Göktuğ Savaş, Ali Riza Akyüz, Şükriye Uslu, Muhammed Esad Çekin, Ayşe Hoşoğlu, Ali Bağci, Abdulsamet Arslan, et al.

    BACKGROUND: Isolated coronary artery ectasia (CAE) is a less common form of CAE. The clinical significance of isolated CAE has not been elucidated yet. We aimed to compare the patients with myocardial infarction (MI) due to isolated CAE with the patients without CAE. METHODS: We retrospectively included patients who underwent coronary angiography with a diagnosis of first MI caused by isolated CAE. We excluded patients with >20% stenosis in any vessel other than the lesion responsible for the MI. A second group of patients with MI without CAE was selected as the control group. The primary outcome was the composite of all-cause death and nonfatal recurrent MI occurring after index hospitalization. RESULTS: A total of 404 patients were included. Overall, 63.9% of MIs were ST-elevation MI. Almost all patients in the isolated CAE group had multivessel diffuse ectasia, with 71.3% classified as Markis I, and 26.7% as Markis II. Death or MI recurrence occurred in 54 (26.7%) patients in the isolated CAE group and 33 (16.3%) patients in the control group ( P =0.011). Death occurred in 8 (4.0%) patients in the isolated CAE group versus 6 (3.0%) patients in the control group; recurrent MI in 46 (22.8%) versus 27 (13.4%) patients, respectively. Stent thrombosis was more common in the CAE group compared with the control group (8.9% versus 1.5%; P P =0.017), and recurrent MI (hazard ratio, 2.07 [95% CI, 1.08–3.96]; P =0.029). CONCLUSIONS: The patients with MI due to isolated CAE had a higher risk of recurrent MI and stent thrombosis compared with the patients without CAE. In this study, the rate of recurrent MI from the index infarct artery was also higher in the patients with CAE.


  • The relationship between lactate to albumin ratio and in-hospital mortality in critically ill patients with acute decompensated heart failure

    by Yusuf Hoşoğlu, Mehmet Göl, Ayşe Hoşoğlu, Hakan Tibilli, Veysi Kavalcı, Abdulmecit Afşin

    Aim: This study aimed to evaluate the association between admission lactate to albumin ratio (LAR) and in-hospital mortality in critically ill patients hospitalized with acute decompensated heart failure (ADHF).Material sand Methods: This retrospective single-center study included 87 adult patients admitted to a coronary intensive care unit (ICU) with ADHF. LAR was calculated using admission laboratory values. Patients were classified according to in-hospital survival status. Clinical, laboratory, and echocardiographic variables were analyzed to identify predictors of in-hospital mortality. Receiver operating characteristic (ROC) analysis was performed to assess the prognostic performance of the LAR.Results: In-hospital mortality occurred in 29 of 87 patients (33.3%). Median lactate levels were significantly higher in non-survivors compared with survivors (3.47 vs. 2.10 mmol/L, p < 0.001). The LAR was also higher in non-survivors (0.93 vs. 0.59, p = 0.002), while left ventricular ejection fraction (LVEF) was lower (28.2% vs. 36.1%, p = 0.006). In multivariable logistic regression analysis, mechanical ventilation (adjusted OR 80.8, p < 0.001) and LVEF (adjusted OR 0.92 per %, p = 0.016) were independently associated with in-hospital mortality, whereas the LAR was not (p = 0.266). ROC analysis demonstrated fair discrimination for the LAR in predicting mortality (AUC 0.706).Conclusion: Although higher LAR values were associated with mortality in unadjusted analysis, this marker did not provide independent prognostic value beyond established indicators of disease severity in critically ill patients with ADHF.


  • Open Access

    Predictors of 10-Year Survival After Transcatheter Aortic Valve Replacement with First-Generation Aortic Valve: Insights from A Single Center Initial Experience

    by Ayşe Hoşoğlu, Merih Kutlu, Ömer Gedikli, Hüseyin İnCe

    Aim: This study aimed to identify predictors of 10-year survival in patients undergoing early Transcatheter Aortic Valve Replacement (TAVR) with the first-generation CoreValve system, providing insights from a pioneering single-center experience in Turkey.Material and Methods: We retrospectively analyzed high-risk patients who underwent TAVR between April 2012 and March 2013. Baseline clinical characteristics and echocardiographic parameters were compared between survivors and non-survivors over a 10-year follow-up period. Survival analysis was performed using Kaplan-Meier curves, and Cox regression models were utilized to identify independent predictors of survival.Results: The cohort included patients with a mean age of 77.1 ± 7.7 years. The Kaplan–Meier analysis estimated the median survival time at 62 months (95% CI: 33–127), with a mean survival time of 71.6 months (95% CI: 43.9–99.3). Survivors exhibited significantly lower left ventricular (LV) end-diastolic diameter, LV mass index, and LV diastolic-systolic diameter difference compared to non-survivors. In univariate analysis, STS score, pulmonary artery pressure (PAP), LV hypertrophy pattern, LV diameter difference, and LV mass index emerged as potential predictors of long-term survival. STS score and LV diameter difference were independent predictors.Conclusion: In this study, both STS score and LV diastolic-systolic diameter difference were identified as independent predictors of 10-year survival following TAVR. These findings emphasize the critical role of precise patient evaluation and underscore the potential value of personalized procedural strategies to optimize long-term outcomes in TAVR patients

  • Kalıcı Kalp Pili Endikasyonları

    by Yusuf Hoşoğlu, Ayşe Hoşoğlu

  • Open Access

    İmplante Edilebilir Kardiyak Elektronik Cihazlar

    by Gamze Yeter Arslan, Yusuf Hoşoğlu, Ayşe Hoşoğlu, Yakup Yiğit, Didar Elif Akgün, Yavuz Selim Akgün, Tarık Yıldırım, Seda Elçim Yıldırım, Arzu Yazar, Neşri Danışman, et al.

    Kardiyak Pace Tipi ve Pacing Modları Gamze Yeter ARSLAN Kalıcı Kalp Pili Endikasyonları Yusuf HOŞOĞLU Ayşe HOŞOĞLU Pacemaker & ICD İmplantasyonu Yakup YİĞİT Leadless Pacemaker Yusuf Ziya ŞENER Geçici Transvenöz Pacing ve Komplikasyonları Didar Elif AKGUN Yavuz Selim AKGUN Primer Koruma Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Tarık YILDIRIM Sekonder Profilaksi Amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör Seda Elçim YILDIRIM İmplante Edilebilir Kardiyoverter-Defibrilatör Programlama Arzu YAZAR İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Mevcut Hastalarda Uygun Cihaz Şoklarının Yönetimi Neşri DANIŞMAN Şeyhmus KULAHCIOĞLU Uygunsuz İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Şokları ve Yönetimi Onur ALTINKAYA Subkutan ICD Ertan AYDIN Giyilebilir Kardiyak Defibrilatör Abdullah SARIHAN Lütfü BEKAR Genetik Testler Selahattin AKYOL Holter Ritim Monitörizasyonu Sinem ÖZBAY ÖZYILMAZ İmplante Edilebilir Loop Recorder Hatice TAŞKAN Tilt Table Testi Güney SARIOĞLU Pacemaker ve ICD Endikasyonu Belirlemede Kullanılan Testler-Kardiyak Görüntüleme (EKO ve MRG) Emirhan ÇAKIR Elektrofizyolojik Çalışma Muhammed Kemal KAHYALAR Kalp Yetersizliği Tedavisinde Kardiyak Resenkronizasyon Tedavisi Enfal ÇAKMAK AKSU Fatih AKKAYA Kardiyak Resenkronizasyon Tedavisi Endikasyonları ve Hasta Seçimi Tayfur ERDOĞDU Koroner Sinüs Anatomisi ve KRT Doğan İLİŞ KRT İmplantasyonu Kubilay ERSELCAN Cerrahi KRT İmplantasyonu Mahmut YARGI Kime KRT-D & Kime KRT-P Fahri CAKAN Kardiyak Resenkronizasyon Tedavisi Yanıt Tanımı ve İlişkili Faktörler Lütfü AŞKIN Elektrokardiyografi ve Ekokardiyografi ile Kardiyak Resenkronizasyon Tedavisi Optimizasyonu Şerif HAMİDEYİN Kardiyak Resenkronizasyon Tedavisi Programlama Fatih KÖKSAL Diyafragma Pacingi Yönetimi Emre ASİLTÜRK Atriyal Fibrilasyonda Atrioventriküler (AV) Nod Ablasyonu ve Kardiyak Resenkronizasyon Tedavisi Halil İbrahim DURMUŞ HİS-Demeti Pacing Ayça ARSLAN Sol Dal Pacing İnanç ARTAÇ HİS Optimize Kardiyak Resenkranizasyon Tedavisi Süleyman BARUTCU Sol Dal Optimize Kardiyak Resenkronizasyon Tedavisi Hakan Gökalp UZUN Jeneratör Replasmanı Yusuf Bozkurt ŞAHİN Lead Ekstraksiyonu Nihan BAHADIR Kardiyak İmplante Edilebilir Elektronik Cihazların (KİEC) İmplantasyonu Sonrası Takip Şeyhmus Erkan DEMİRCAN Baver EKİNCİ Atrial Yüksek Hız Epizot Yönetimi Muhammet GENEŞ Kardiyak İmplante Edilebilir Cihazlarda Telekardiyografik Değerlendirme Zelal TAHAOĞLU Pil Cebi Hematomu Sidar Şiyar AYDIN Pnömotoraks, Hemotoraks ve Brakiyal Pleksus Yaralanması Ali Nail KAYA Kardiyak İmplante Edilebilir Elektronik Cihazların Komplikasyonu Kardiyak Rüptür/Perikardiyal Efüzyon Burcu KODAL Lead Kusurları Mert Pehlivan ALTIN Lead Dislokasyonu Sendromları Vedat CİCEK Samet YAVUZ Lead İlişkili Triküspit Yetmezliği Timor OMAR Pacemaker Aracılı Taşikardi Lütfullah CANDAN Pacemaker Sendromu Murat KARACAM Gülümser Sevgin HALİL Oversense Sendromları Selahattin AYDIN Kardiyak İmplante Edilebilir Cihaz Enfeksiyonu Mürsel ŞAHİN Kiec İlişkili Lead Trombüsü ve Pulmoner Embolizm Emre YILMAZ Karotid Baroreseptör Stimülasyonu Fehmi ESER Ramazan DUZ Kardiyak Kontraktilite Modülasyonu Sümeyye Fatma ÖZER Pulmoner Arter Basıncı Monitorizasyonu Muammer KARAKAYALI Kardiyak İmplante Edilebilir Elektronik Cihaz İmplantasyon Sürecinde Antikoagülan Tedavi ve Antibiyotik Proflaksisi Ömer ŞİT Preoperatif Kardiyak İmplante Edilebilen Cihaz Ayarlama Ferit BÖYÜK Radyoterapi Sürecinde Kalp Pili & ICD Takibi Yusuf Ziya ŞENER Kardiyak İmplante Edilebilir Elektronik Cihazı Olan Hastada Manyetik Rezonans Görüntüleme Semih KALKAN Kalp Pili & İmplante Edilebilir Kardiyak Defibrilatör (ICD) Olan Hastalarda Spor Aktivitesi ve Sürücülük Ahmet Lütfü SERTDEMİR Ahmet Taha ŞAHİN LVAD İmplantasyonu Yapılan Hastada ICD Endikasyonu ve Yönetimi Berhan KESKİN Kardiyak Cerrahi Sonrası Pacing Muhammed Bahadır OMAR TAVİ Sonrası Pacemaker İmplantasyonu Mehmet KIŞ Çisem OKTAY Konjenital Kalp Hastalıklarında Kardiyak Pacing ve ICD Mücahit TAN Naci BABAT Sarkoidoz Kardiyak Pacing ve ICD Ercan CEĞİLLİ Pakize SUCU Kardiyak Amiloidozda Kardiyak Pacing ve ICD Onur ASLAN Hipertrofik Kardiyomiyopatide Kardiyak Pacing ve ICD Burcu OZYAZGAN Nadir Kardiyak Hastalıklarda Kardiyak Pacing ve ICD Songül USALP

  • Open Access

    Interatrial Block and Ventricular Repolarization Parameters in Young Patients with Mild Acute Myocarditis

    by Yusuf Hoşoğlu, Ayşe HOŞOĞLU, Mehmet Göl, Abdulmecit Afşi̇n

    Objective: To evaluate ECG findings regarding interatrial block and ventricular repolarization and certain biochemical parameters in young patients diagnosed as acute myocarditis with normal ventricular functions. Materials and Methods: 405 patients under the age of 35 who underwent diagnostic coronary angiography between January 2014 and January 2020 were retrospectively analyzed. Patients whose ECG records could not be accessed or quality were not suitable for evaluation, with sudden cardiac death, cardiomyopathy, ejection fraction <50%, diabetes mellitus, hypertension, chronic kidney and liver failure were excluded. Patients who underwent diagnostic angiography for the differential diagnosis of acute myocarditis were assigned to myocarditis group (n: 35), and age– and sex–matched subjects with normal coronary circulation and underwent coronary angiography for any other reason were assigned to control group (n: 35). Results: Heart rate, P wave duration, P wave peak time, PR interval, QRS, QT, and Tp–e interval, QTc, Tp–e/QT and Tp–e/QTc ratios did not differ from each other. Whereas troponin (p<0.001), glucose (p=0.004), LDL (p=0.015), AST (p<0.001), ALT (p<0.026), CRP (p<0.001) levels and neutrophil count (p=0.003) were markedly higher in myocarditis group, HDL was lower (p<0.001). Conclusions: Although biochemical parameters display differences in myocarditis group, ECG findings did not differ.